ログイン

11. TRANSPLANTATION IMMUNOLOGY
30問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    TRANSPLANT TO SAME INDIVIDUAL

    Autograft

  • 2

    SAFEST TRANSPLANT

    Autograft

  • 3

    TRANSPLANT BET. TWINS

    Syngeneic graft/isograft

  • 4

    BET. 2 INDI., SAME SPECIE

    Allograft

  • 5

    TWO DIFFERENT INDIVIDUALS AND SPECIES

    Xenograft/heterograft

  • 6

    CD8+GRAFT CELL -> CELL DEATH

    Direct Recognition

  • 7

    Direct Recognition

    CD8+GRAFT CELL -> CELL DEATH

  • 8

    Indirect Recognition

    CD4+APC W/ MHC II -> CYTOKINES

  • 9

    CD4+APC W/ MHC II -> CYTOKINES

    Indirect Recognition

  • 10

    DONORS CELL DESTROY THE RECIPIENTS TISSUE

    GRAFT VS HOST DISEASE

  • 11

    RESULT IF NOT COMPATIBLE

    GRAFT REJECTION

  • 12

    RECIPENT DESTROY THE TRANSPLANT TISSUE, RECIPIENT REACT IF NOT COMPATIBLE

    GRAFT REJECTION

  • 13

    sites accessible to the immune system in the recipient ARE SUSCEPTIBLE TO

    GRAFT REJECTION

  • 14

    Regulator and Effector of graft rejection:

    CELL MEDIATED

  • 15

    – safest transplant

    Cornea

  • 16

    Active infection- THE MOST IMPORTANT EXCLUSION IN THIS ORGAN

    Heart

  • 17

    ________ – primary method for monitoring organ rejection in Heart

    Endomyocardial BIOPSY

  • 18

    – standard modality for tx of aortic and mitral valve defect

    Xenogenic valve replacement

  • 19

    Sources: bovine and porcine

    Heart Valves

  • 20

    Heart Valves Sources:

    bovine and porcine

  • 21

    Usually transplanted with other organ. Patient w/ short gut syndrome

    Intestine

  • 22

    Donor: stable cardiopulmonary status and liver function

    Intestine

  • 23

    strongest assoc. between Tranplant survival

    Kidney- HLA D (DR,MB,MT)

  • 24

    most common transplant

    Kidney-

  • 25

    Kidney- ref. lab

    NKTI NATIONAL KIDNEY TRANSPLANT INSTITUTE

  • 26

    No need for HLA typing

    Liver

  • 27

    – LARGEST group of transplant recipient

    Congenital Biliary Atresia

  • 28

    – occurs to 30-50% ptx

    Biliary tract fistulae or leak

  • 29

    Biliary tract fistulae or leak – occurs to ?% ptx

    30-50%

  • 30

    - Donor and recipient must have the same BRONCHIAL circumference

    Lungs

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    TRANSPLANT TO SAME INDIVIDUAL

    Autograft

  • 2

    SAFEST TRANSPLANT

    Autograft

  • 3

    TRANSPLANT BET. TWINS

    Syngeneic graft/isograft

  • 4

    BET. 2 INDI., SAME SPECIE

    Allograft

  • 5

    TWO DIFFERENT INDIVIDUALS AND SPECIES

    Xenograft/heterograft

  • 6

    CD8+GRAFT CELL -> CELL DEATH

    Direct Recognition

  • 7

    Direct Recognition

    CD8+GRAFT CELL -> CELL DEATH

  • 8

    Indirect Recognition

    CD4+APC W/ MHC II -> CYTOKINES

  • 9

    CD4+APC W/ MHC II -> CYTOKINES

    Indirect Recognition

  • 10

    DONORS CELL DESTROY THE RECIPIENTS TISSUE

    GRAFT VS HOST DISEASE

  • 11

    RESULT IF NOT COMPATIBLE

    GRAFT REJECTION

  • 12

    RECIPENT DESTROY THE TRANSPLANT TISSUE, RECIPIENT REACT IF NOT COMPATIBLE

    GRAFT REJECTION

  • 13

    sites accessible to the immune system in the recipient ARE SUSCEPTIBLE TO

    GRAFT REJECTION

  • 14

    Regulator and Effector of graft rejection:

    CELL MEDIATED

  • 15

    – safest transplant

    Cornea

  • 16

    Active infection- THE MOST IMPORTANT EXCLUSION IN THIS ORGAN

    Heart

  • 17

    ________ – primary method for monitoring organ rejection in Heart

    Endomyocardial BIOPSY

  • 18

    – standard modality for tx of aortic and mitral valve defect

    Xenogenic valve replacement

  • 19

    Sources: bovine and porcine

    Heart Valves

  • 20

    Heart Valves Sources:

    bovine and porcine

  • 21

    Usually transplanted with other organ. Patient w/ short gut syndrome

    Intestine

  • 22

    Donor: stable cardiopulmonary status and liver function

    Intestine

  • 23

    strongest assoc. between Tranplant survival

    Kidney- HLA D (DR,MB,MT)

  • 24

    most common transplant

    Kidney-

  • 25

    Kidney- ref. lab

    NKTI NATIONAL KIDNEY TRANSPLANT INSTITUTE

  • 26

    No need for HLA typing

    Liver

  • 27

    – LARGEST group of transplant recipient

    Congenital Biliary Atresia

  • 28

    – occurs to 30-50% ptx

    Biliary tract fistulae or leak

  • 29

    Biliary tract fistulae or leak – occurs to ?% ptx

    30-50%

  • 30

    - Donor and recipient must have the same BRONCHIAL circumference

    Lungs